Today, the United States and the European Union signed an administrative arrangement to bring together experts from across the U.S. and Europe to further research on artificial intelligence (AI), computing, and related privacy protecting technologies, as underscored in the U.S.-EU Trade and Technology Council (TTC) commitment. This collaborative effort will drive responsible advancements in AI to address major global challenges with a joint development model and integrated research to deliver benefits to our societies through five key areas of focus: Extreme Weather and Climate Forecasting, Emergency Response Management, Health and Medicine Improvements, Electric Grid Optimization, and Agriculture Optimization. Together, we are confident the results of our research will extend beyond our partnership to benefit additional international partners and the global science community. Today's announcement also builds on the vision set forth in the Declaration for the Future of the Internet (DFI) for an open, free, reliable, and secure Internet and digital technologies around the world. We look forward to deepening our cooperation with the EU through this initiative.

… at their disposal in the battle for direct bookings with the launch of a ‘game-changing’ booking engine powered by artificial intelligence (AI).

BEGIN ARTICLE PREVIEW: Artificial Intelligence Collaboration Seeking to Hasten COVID-19 Insights We store cookies on your computer to improve your experience and provide more personalized services, both on this website and on other sites. For more information about the cookies we use, see our Privacy Policy. We won’t track your information when you visit our site. We will have to use at least one cookie to ensure that you won’t have to make this choice again.AcceptDeclinePrivacy Policy END ARTICLE PREVIEW READ MORE FROM SOURCE ARTICLE

IMAGE: Purdue University is joining with other organizations for an initiative to accelerate global collaborative research on COVID-19 through access to high-quality, real-time multi-center patient datasets. WEST LAFAYETTE, Ind. - During the COVID-19 pandemic, health care professionals and researchers have been confined mostly to using local and national datasets to study the impact of comorbidities, pre-existing medication use, demographics and various interventions on disease course. Now, Purdue University is joining with other organizations for an initiative to accelerate global collaborative research on COVID-19 through access to high-quality, real-time multi-center patient datasets. The National Science Foundation has provided funding to develop the Records Evaluation for COVID-19 Emergency Research (RECovER) initiative. Researchers are testing predictions of artificial intelligence drug discovery platforms from the lab of Gaurav Chopra, an assistant professor of analytical and physical chemistry in Purdue's College of Science, on patient datasets across a network of health care institutions.

IMAGE: Purdue College is becoming a member of with different organizations for an initiative to speed up world collaborative analysis on COVID-19 by means of entry to high-quality, real-time multi-center affected person datasets. WEST LAFAYETTE, Ind. – In the course of the COVID-19 pandemic, well being care professionals and researchers have been confined largely to utilizing native and nationwide datasets to review the influence of comorbidities, pre-existing remedy use, demographics and varied interventions on illness course. Now, Purdue College is becoming a member of with different organizations for an initiative to speed up world collaborative analysis on COVID-19 by means of entry to high-quality, real-time multi-center affected person datasets. The Nationwide Science Basis has supplied funding to develop the Information Analysis for COVID-19 Emergency Analysis (RECovER) initiative. Researchers are testing predictions of artificial intelligence drug discovery platforms from the lab of Gaurav Chopra, an assistant professor of analytical and bodily chemistry in Purdue's Faculty of Science, on affected person datasets throughout a community of well being care establishments.

Artificial Intelligence (AI) is increasingly being used in medicine to support human expertise. However, the potential of these applications and the risks inherent in the interaction between human and artificial intelligence have not yet been thoroughly researched. The fear is often expressed that in future, as soon as AI is of sufficient quality, human expertise will become dispensable and therefore fewer doctors will be needed. These fears are further fuelled by the popular portrayal of this as a "competition" between humans and AI. An international study led by MedUni Vienna has now illustrated the enormous potential of human/computer collaboration.